Literature DB >> 11150030

Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications.

A Machens1, R Hinze, C Lautenschläger, O Thomusch, H Dralle.   

Abstract

BACKGROUND: Controversy exists about the routes of invasion (extrathyroidal versus lymphogenic extension) when differentiated carcinoma (DTC) and medullary thyroid carcinoma (MTC) invade the cervicovisceral axis (ie, larynx, trachea, esophagus).
METHODS: We carried out an institutional analysis, from November 1994 to October 1999, of 451 consecutive patients undergoing surgery for DTC and MTC.
RESULTS: Irrespective of tumor entity, carcinomas with cervicovisceral invasion (n = 34) were significantly larger and displayed higher pT categories (mainly pT4) than noninvasive carcinomas. In invasive papillary thyroid carcinoma (PTC) and MTC, the rates of positive lymph nodes were significantly higher than in noninvasive controls. When separate logistic regression analyses were fitted for laryngeal, tracheal, and esophageal invasion, extrathyroidal growth (pT4) consistently was a significant factor predictive of invasion in both DTC and MTC, with relative risks of 10.9 to 67.8. As the routes of invasion are similar in DTC and MTC, all data were pooled for multivariate analyses. Herein, the pN1 category had a significant impact only on esophageal invasion, with a relative risk of 4.7.
CONCLUSIONS: Invasion of the cervicovisceral axis is more often caused by extrathyroidal growth than by nodal metastasis. To keep nodal metastasis from encroaching onto the cervicovisceral axis, paratracheal and paraesophageal lymph nodes should be cleared from the cervicocentral compartment at the primary operation.

Entities:  

Mesh:

Year:  2001        PMID: 11150030     DOI: 10.1067/msy.2001.108699

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  16 in total

1.  Pattern of initial metastasis in the cervical lymph node from papillary thyroid carcinoma.

Authors:  Naoyoshi Onoda; Tetsuro Ishikawa; Hidemi Kawajiri; Tsutomu Takashima; Kosei Hirakawa
Journal:  Surg Today       Date:  2012-06-26       Impact factor: 2.549

Review 2.  Management of Invasive Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Ricard Simo; Kate Newbold; Alessandra Rinaldo; Carlos Suarez; Luiz P Kowalski; Carl Silver; Jatin P Shah; Alfio Ferlito
Journal:  Thyroid       Date:  2016-08-23       Impact factor: 6.568

3.  Operative management of locally advanced, differentiated thyroid cancer.

Authors:  Laura Y Wang; Iain J Nixon; Snehal G Patel; Frank L Palmer; R Michael Tuttle; Ashok Shaha; Jatin P Shah; Ian Ganly
Journal:  Surgery       Date:  2016-06-11       Impact factor: 3.982

Review 4.  [Extrathyroidal thyroid cancer : results of tracheal shaving and tracheal resection].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2011-02       Impact factor: 0.955

5.  Thyroid cancer with tracheal invasion: a pathological estimation.

Authors:  Vincenzo Pappalardo; Stefano La Rosa; Andrea Imperatori; Nicola Rotolo; Maria Laura Tanda; Andrea Sessa; Lorenzo Dominioni; Gianlorenzo Dionigi
Journal:  Gland Surg       Date:  2016-10

6.  [Surgery of thyroid carcinoma].

Authors:  H Dralle; K Lorenz; A Machens
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

Review 7.  Invasive thyroid cancer: management of the trachea and esophagus.

Authors:  Daniel L Price; Richard J Wong; Gregory W Randolph
Journal:  Otolaryngol Clin North Am       Date:  2008-12       Impact factor: 3.346

Review 8.  [Cervicovisceral resection in invasive thyroid tumors].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

9.  The role of laryngectomy in locally advanced thyroid carcinoma. Review of 16 cases.

Authors:  A I Chala; S Vélez; A Sanabria
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

10.  Clinical predictors of right upper paraesophageal lymph node metastasis from papillary thyroid carcinoma.

Authors:  Yong-Seok Kim; Woo-Chan Park
Journal:  World J Surg Oncol       Date:  2012-08-16       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.